Complications of chemotherapy Flashcards

1
Q

Other cells affected

A
  • Hair follicles
  • Stem cells
  • Mucosal cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Common side-effects of chemotherapy

A
  • Nausea + vomiting
  • Diarrhoea
  • Mucositis
  • Hair loss
  • Fatigue
  • Immunosuppression (infection)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why does N + V occur?

A
  • The body sees medicine as foreign.
  • Actives chemoreceptor trigger zone.
  • Sets of warning signals in brain and digestive system.
  • Activation of vomiting centre.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of N + V

A
  • Acute
  • Delayed
  • Anticipatory
  • Breakthrough
  • Refractory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acute N + V

A

Occurs during the first 24 hours after chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Delayed

A
  • Occurs more than 24 hours after chemo
  • May continue for up to 6-7 days after.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anticipatory

A
  • N + V that occurs prior to beginning a new cycle of chemo.
  • Common after 3-4 cycles after chemo.
  • Badly controlled acute or delayed symptoms.
  • May be a learned response:
    • Following N + V induced on a previous cycle
    • Anxiety response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Breakthrough

A
  • Development of N + V despite standard anti-emetic therapy.
  • Requires treatment with an additional pharmacological agent.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Refractory

A
  • Failed treatment of both standard and rescue medicine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cisplatin

A
  • Grade 3 N+ V, if no anti-emetic administered.
  • N = Inadequate caloric intake, IV fluid, tube feedings, TPN indicated> 24 hours.
  • V = 6+ episodes in 24 hours
  • Use moderate/high risk regime + APREPITANT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Low risk N + V - Drug regime

A
  • E.g. single agent fluorouracil regimes.
  • Monotherapy with dopamine antagonist
  • First dose pre-chemo, then regularly for 5-7 days (or PRN).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Moderate/high risk N +V- Drug regime

A

Pre-chemo:
- Dexamethasone + 5HT-3 antagonist

Post-chemo:
- Dexamethasone + 5HT-3 antagonist + dopamine antagonist
- 5-7 days after

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diarrhoea

A
  • Incidence varies
  • Loperamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mucositis

A
  • Early treatment is required to minimise eating/drinking issues.
  • Mouthwashes
    • Difflam
    • Chlorhexidine
  • Good oral hygiene
  • Soft-bristled toothbrush
    • Avoid cutting gums
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hair loss

A

Extent of hair loss varies between different drugs.
- Scalp cooling (cold-caps)
- Time-consuming and not particularly comfortable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fatigue

A
  • Results from the stress of chemo or N + V
  • Performace status monitored between cycles.
  • Poor PS = delay or stop chemo
17
Q

Performace status

A

0 = no symptoms, average activity level.
1 = symptomatic, can carry out normal daily activities.
2 = Symptomatic, bed less than half the day, some assistance required.
3 = Symptomatic, bed more than half the day.
4 = Bedridden

18
Q

Haematological side-effects

A
  • Myelosuppression
  • Thrombocytopenia
  • Neutropenia
19
Q

Monitoring for haematological side-effects

A
  • FBC before each cycle - delays/dose reduction if inadequate.
    • WCC = 3 or above
    • Neutrophils = 1/1.5 or above
    • Platelets = 100 or above
  • Counsel patients to be vigilant and report possible symptoms
  • Transfusion if very low Hb (anaemia)
20
Q

Myelosuppression

A
  • Decreased bone marrow activity
  • Fewer RBCs, WBCs and platelets.
21
Q

Myelosuppression - management

A
  • Transfusions
  • Growth factors
  • Time between doses
  • Isolation in sterile environment
22
Q

WBC normal range (x10*9/L)

A

4-11

23
Q

Platelets normal range (x10*9/L)

A

150-400

24
Q

Neutrophils normal range (x10*9/L)

A

2-7.5

25
Q

Tumour lysis syndrome

A
  • Tumour cells release their contents into the bloodstream spontaneously or in response to therapy.
  • Associated with aggresive/large haematological cancers (high cell burden)
26
Q

Tumour lysis syndrome - process

A
  • Chemotherapy causes mass cell lysis.
  • Uric acid (and electrolytes) released from cells as they break down.
  • Deranged U+Es = acute kidney injury.
27
Q

Tumour lysis syndrome

A
  • Prevention is curcial
  • Allopurinol or rasburicase
    • Promote excretion of uric acid.
28
Q

Subfertility

A
  • Spermbanking
  • IVF
29
Q

Cardiomyopathy

A
  • ECG monitoring
  • Cardiac glycosides
30
Q

Hepatotoxicity

A

Liver function tests (pre and post)

31
Q

Nephrotoxicity / Haemorrhagic cystitis

A

Hydration and forced diuresis (for ifosfamide and cyclophosphamide)

32
Q

Patient education

A
  • Balnced info on side-effects and benefits of treatment.
  • Adress:
    • What are the side effects?
    • How likely are they to happen to me?
    • What should I do if they occur?
33
Q

Aims of treatment

A
  • Reduce discomfort
  • Reduce morbidity and mortality
  • Increase tolerable dose threshold